Study Summary
A Clinical Study on the Safety and Effectiveness of targeting CD5 CAR-T Cells in the treatment of r/r CD5+ T-ALL
Want to learn more about this trial?
Request More InfoInterventions
CD5 CAR T-cellsBIOLOGICAL
Each subject receive CD5+ T-ALL Targeted CAR T-cells by intravenous infusion
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| The first affiliated hospital of medical college of zhejiang university | Hangzhou | Zhejiang | China |